InvestorsHub Logo
Followers 23
Posts 3110
Boards Moderated 1
Alias Born 04/29/2019

Re: None

Monday, 02/06/2023 9:25:24 AM

Monday, February 06, 2023 9:25:24 AM

Post# of 167470
FRANKFURT, Germany & LONDON–(BUSINESS WIRE)– International medical cannabis company Akanda Corp. (NASDAQ: AKAN) today (1-2-23) announced that it successfully launched its initial supply to German customers recognizing approximately €1,803,996M 1 in sales of EU GMP high-quality indoor-grown medical cannabis in the last quarter of 2022. On a preliminary, unaudited basis, Akanda has recognized its first material revenues since its inception, validating the Company’s strategy to enter the European markets supplying high-end indoor-grown cannabis.

I think PG (Gurney) said shit like this about CBDD last year?...Dick!